Data / Drug companies / Alivus Life Sciences Limited
Alivus Life Sciences Limited: 109 products in the FDA NDC directory, labeler code 66039
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Alivus Life Sciences Limited (labeler code 66039) lists 109 products in the FDA National Drug Code Directory. By type: 109 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on August 10, 2026.
The request: Watch Alivus Life Sciences Limited (FDA labeler code 66039): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 66039
- Products in commercial distribution
- 109
- Packages
- 109
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 4, Schedule V 3
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- October 2, 2003
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 109 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 109 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 109 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Azelaic acid | 66039-985 | Powder | Bulk ingredients | August 10, 2026 |
| Viloxazine hydrochloride | 66039-980 | Powder | Bulk ingredients | December 23, 2025 |
| Bupropion hydrobromide | 66039-863 | Powder | Bulk ingredients | March 29, 2025 |
| Ruxolitinib phosphate | 66039-976 | Powder | Bulk ingredients | March 27, 2025 |
| Relugolix | 66039-974 | Powder | Bulk ingredients | March 26, 2025 |
| Raloxifene hydrochloride | 66039-961 | Powder | Bulk ingredients | March 25, 2025 |
| Finerenone | 66039-975 | Powder | Bulk ingredients | March 24, 2025 |
| Tivozanib hydrochloride monohydrate | 66039-973 | Powder | Bulk ingredients | December 16, 2024 |
| Fluvoxamine maleate | 66039-971 | Powder | Bulk ingredients | July 1, 2024 |
| Propranolol hydrochloride | 66039-972 | Powder | Bulk ingredients | March 29, 2024 |
| Sodium bicarbonate | 66039-970 | Powder | Bulk ingredients | March 28, 2024 |
| Roflumilast | 66039-964 | Powder | Bulk ingredients | March 28, 2024 |
| Brivaracetam | 66039-967 | Powder | Bulk ingredients | November 6, 2023 |
| Trazodone hydrochloride | 66039-965 | Powder | Bulk ingredients | September 29, 2023 |
| Olaparib | 66039-968 | Powder | Bulk ingredients | September 28, 2023 |
| Isavuconazonium sulfate | 66039-963 | Powder | Bulk ingredients | November 30, 2022 |
| Labetalol hydrochloride | 66039-962 | Powder | Bulk ingredients | August 8, 2022 |
| Tafamidis | 66039-960 | Powder | Bulk ingredients | February 10, 2022 |
| Tafamidis meglumine | 66039-959 | Powder | Bulk ingredients | February 10, 2022 |
| Hydralazine hydrochloride | 66039-957 | Powder | Bulk ingredients | February 24, 2021 |
| Verapamil hydrochloride | 66039-956 | Powder | Bulk ingredients | November 28, 2020 |
| Rosuvastatin calcium | 66039-955 | Powder | Bulk ingredients | October 27, 2020 |
| Solriamfetol hydrochloride | 66039-953 | Powder | Bulk ingredients | September 8, 2020 |
| Iron sucrose | 66039-954 | Powder | Bulk ingredients | July 31, 2020 |
| Lifitegrast | 66039-948 | Powder | Bulk ingredients | August 29, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.